Corcept Therapeutics options trading suggests a position designed to benefit from a substantial share-price move in either direction, according to Investing.com. The outlet identified the activity as a long strangle and linked the positioning to the period ahead of 2027.

The available reporting does not provide the contracts’ strike prices, expiration dates, premiums or size. It also does not identify the trader. Those omissions limit what can be established about the position’s cost, precise timing and potential payoff. The reference to 2027 does not, by itself, establish when the contracts expire.

Corcept, which trades under the ticker CORT, is a pharmaceutical company whose work focuses on treatments involving the hormone cortisol. The reported options activity concerns contracts tied to its shares. It does not establish a change in the company’s operations or identify a particular corporate announcement behind the trade.

An option gives its buyer a contractual right tied to an underlying asset. For stock options, a call gives the holder the right to buy shares at a specified price, while a put gives the holder the right to sell. Buyers pay a premium for those rights, which last for a defined period.

How a long strangle works

A conventional long strangle combines the purchase of a call above the current share price with the purchase of a put below it, normally using the same expiration date. These specified purchase and sale prices are known as strikes. Both contracts typically begin out of the money, meaning immediate exercise would offer no economic benefit.

The structure provides exposure to a strong advance or a steep decline. At expiration, the call has value if the stock finishes above its strike; the put has value if the stock finishes below its strike. If the shares finish between the two strikes, both options expire without value.

Simply crossing a strike does not make the combined position profitable. The payoff must also cover the premiums paid for both contracts. Excluding transaction costs, the upper break-even price at expiration is the call strike plus the combined premium per share. The lower break-even price is the put strike minus that premium.

For a standalone position consisting only of purchased options, the maximum loss is the amount paid, plus transaction costs. That loss occurs at expiration when neither option has value. Without the reported trade’s prices and strikes, its break-even levels cannot be calculated.

What affects the contracts before expiration

Before expiration, option values also reflect remaining time and implied volatility, a measure embedded in prices that describes the scale of movement the market is pricing. Higher implied volatility generally supports the value of purchased calls and puts, other factors held constant.

The passage of time generally reduces their time value, other factors held constant. A long strangle can therefore lose value even while the underlying shares move, if that movement is insufficient or a decline in implied volatility offsets it. Expiration payoff diagrams do not capture every possible outcome from selling the contracts earlier.

What to watch

The missing strikes, premiums and expiration dates are the details needed to assess the reported position. Confirmation that the call and put purchases were linked would also strengthen the identification of the activity as a single strategy.